The nationally collaborative project, led by Monash University and supported by researchers and clinicians across Austra...
Molbio Diagnostics, India’s leading in-vitro diagnostics company and inventor of the Truenat technology, has launc...
China's JOYSBIO, one of the world's leading manufacturers of lateral flow rapid test kits, has announced the development...
The US Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Targe...
Hong Kong-based startup Prenetics has announced the launch of Circle Snapshot, a variety of at-home blood tests that fea...
WeTrade Group, an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud i...
LordsMed, the pharma division of Indian firm Lord's Mark Industries, has entered into an exclusive partnership with Sing...
In alignment with the World Health Organization (WHO)’s call to eliminate hepatitis C (HCV) by 2030, Singapore's H...
Japan-based Shimadzu Corporation is participating in the project “Creating a System for Maintaining the Mental Hea...
Singapore-based diagnostics developer and medical laboratory operator INEX Innovate has contributed an undisclosed sum t...
Japanese firm Fujifilm Corporation has announced the opening of two new NURA health screening centres focusing on cancer...
Seegene Inc., South Korea's leading molecular diagnostics company, will work with test centre, LabHouse, to la...
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, has entered into a strat...
Singapore-based iGene Laboratory, the molecular diagnostics laboratory subsidiary of INEX Innovate, has announced the la...
ASUS and Tan Tock Seng Hospital (TTSH) have inked a three-year Memorandum of Understanding (MoU) to formalise ...
How is QIAGEN helping to reduce the growing burden of TB in APAC? QIAGEN promotes TB prevention (Test and Treat strateg...
Seegene Inc., South Korea-based molecular diagnostics (MDx) company, has developed a PCR test to detect the mo...
As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, China-based Joysbio has dev...
